Correct Nyxoah logo.png
Nyxoah to Participate in Annual Piper Sandler Healthcare Conference
20. November 2020 01:25 ET | Nyxoah
PRESS RELEASE Nyxoah to Participate in Annual Piper Sandler Healthcare Conference   Mont-Saint-Guibert, Belgium – 20th November 2020 – Nyxoah S.A. (EBR: NYXH) (“Nyxoah” or the “Company”), a...
Correct Nyxoah logo.png
First Patient Implanted in the DREAM US Pivotal IDE Study, with the Genio® System for the Treatment of Obstructive Sleep Apnea (OSA)
17. November 2020 01:00 ET | Nyxoah
First Patient Implanted in the DREAM US Pivotal IDE Study, with the Genio® System for the Treatment of Obstructive Sleep Apnea (OSA) DREAM is a pivotal, Investigational Device Exemption (IDE) study,...
Correct Nyxoah logo.png
Nyxoah Announces Commencement of Trading of Shares on Euronext Brussels
18. September 2020 01:00 ET | Nyxoah
An investment in the Offered Shares involves substantial risks and uncertainties.  Prospective investors should read the entire prospectus, and, in particular, should see "Risk Factors" for a...
Correct Nyxoah logo.png
Nyxoah Raises up to €85 million (US$100m) in Successful Initial Public Offering
17. September 2020 08:41 ET | Nyxoah
 An investment in the Offered Shares involves substantial risks and uncertainties.  Prospective investors should read the entire prospectus, and, in particular, should see "Risk Factors" for a...
Nyxoah Announces Int
Nyxoah Announces Intention to Launch an Initial Public Offering on Euronext Brussels
27. August 2020 01:00 ET | Nyxoah
An investment in the Offered Shares involves substantial risks and uncertainties.  Prospective investors should read the entire prospectus, and, in particular, should see "Risk Factors" for a...
Correct Nyxoah logo.png
Nyxoah receives IDE approval from the U.S. Food and Drug Administration (FDA) for its DREAM study
25. Juni 2020 02:00 ET | Nyxoah
Nyxoah receives IDE approval from the U.S. Food and Drug Administration (FDA) for its DREAM study Study supporting the approval of Nyxoah’s Genio® system in the U.S. to be initiated in the coming...
Correct Nyxoah logo.png
Nyxoah announces data demonstrating the benefits and safety of its Genio® system implantation technique for the treatment of Obstructive Sleep Apnea published in Laryngoscope Investigative Otolaryngology
27. November 2019 02:00 ET | Nyxoah
Nyxoah announces data demonstrating the benefits and safety of its Genio® system implantation technique for the treatment of Obstructive Sleep Apnea published in Laryngoscope Investigative...
Correct Nyxoah logo.png
Nyxoah publishes positive Obstructive Sleep Apnea data from BLAST OSA study in the European Respiratory Journal
28. Oktober 2019 03:00 ET | Nyxoah
  Nyxoah publishes positive Obstructive Sleep Apnea data from BLAST OSA study in the European Respiratory Journal Compelling data published in prestigious journal show safety and efficacy of the...